Ansel Hillmer, PhD, and Eric Webb, PhD, have received a $100,000 SNMMI grant for developing a novel PET radiotracer targeting brain inflammation in Alzheimer's disease.
Key Details
- 1Awarded the $100,000 Drs. Jane & Abass Alavi Mars Shot Research Award from SNMMI's 2026 fund.
- 2Research targets colony stimulating factor 1 receptor (CSF1R) as a novel inflammation marker in Alzheimer’s.
- 3Project focuses on developing and validating 18F-PLX5622 as a PET radiotracer.
- 4Initial studies will use mouse models; human tissue validation will follow.
- 5The aim is to enable CSF1R imaging for diagnosis, monitoring, and potential treatment guidance in Alzheimer’s patients.
- 6SNMMI Mars Shot Fund established in 2023 to support visionary nuclear imaging research.
Why It Matters
This research could lead to significant advances in the imaging and understanding of brain inflammation in Alzheimer’s disease, enabling better diagnosis and targeted therapy. It also demonstrates ongoing innovation in PET radiotracer development for neurodegenerative disorders.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.